Browse
Explore conditions, clinical trials, and the organisations running them.
Find a condition
Search the conditions that have clinical trials.
7531 conditions with clinical trials.
- Indolent primary cutaneous T-cell lymphoma 0 trials · 3,194 incl. sub-types
- Childhood precursor T-lymphoblastic lymphoma/leukemia 0 trials · 3,182 incl. sub-types
- Gastrointestinal lymphoma 0 trials · 3,171 incl. sub-types
- Eye lymphoma 0 trials · 3,162 incl. sub-types
- Erythroid neoplasm 0 trials · 3,142 incl. sub-types
- Acute myeloid leukemia by FAB classification 0 trials · 3,136 incl. sub-types
- Neoplasm of immature B and T cells 0 trials · 3,130 incl. sub-types
- Childhood brain stem glioma 0 trials · 3,125 incl. sub-types
- Breast lymphoma 0 trials · 3,104 incl. sub-types
- Dendritic cell sarcoma 0 trials · 3,103 incl. sub-types
- Pediatric fibrosarcoma 0 trials · 2,970 incl. sub-types
- Carcinoma of lip 0 trials · 2,956 incl. sub-types
- Sensory system cancer 0 trials · 2,949 incl. sub-types
- Waldeyer's ring cancer 0 trials · 2,948 incl. sub-types
- Soft palate cancer 0 trials · 2,943 incl. sub-types
- Hard palate cancer 0 trials · 2,942 incl. sub-types
- Malignant tumor of floor of mouth 0 trials · 2,941 incl. sub-types
- Childhood malignant kidney neoplasm 0 trials · 2,940 incl. sub-types
- Small intestinal sarcoma 0 trials · 2,938 incl. sub-types
- Spleen cancer 0 trials · 2,933 incl. sub-types
- Central nervous system endodermal sinus tumor 0 trials · 2,928 incl. sub-types
- Cecum cancer 0 trials · 2,922 incl. sub-types
- Ovarian sarcoma 0 trials · 2,922 incl. sub-types
- Cecum adenocarcinoma 0 trials · 2,918 incl. sub-types
- Diencephalic astrocytomas 0 trials · 2,917 incl. sub-types
- Malignant childhood germ cell neoplasm 0 trials · 2,891 incl. sub-types
- Childhood endodermal sinus tumor 0 trials · 2,890 incl. sub-types
- Anal canal adenocarcinoma 0 trials · 2,887 incl. sub-types
- Anus adenocarcinoma 0 trials · 2,887 incl. sub-types
- Anaplastic cancer 0 trials · 2,885 incl. sub-types
- Colorectal signet ring cell carcinoma 0 trials · 2,885 incl. sub-types
- Malignant mixed neoplasm 0 trials · 2,884 incl. sub-types
- Intestine carcinoma in situ 0 trials · 2,882 incl. sub-types
- Rectosigmoid junction cancer 0 trials · 2,877 incl. sub-types
- Retinal cell cancer 0 trials · 2,875 incl. sub-types
- Descending colon cancer 0 trials · 2,873 incl. sub-types
- Pancreatic intraductal papillary-mucinous carcinoma 0 trials · 2,873 incl. sub-types
- Bone carcinoma 0 trials · 2,872 incl. sub-types
- Cardiovascular cancer 0 trials · 2,872 incl. sub-types
- Skull cancer 0 trials · 2,872 incl. sub-types
- PAX6-related ocular dysgenesis 0 trials · 2,869 incl. sub-types
- Pharynx carcinoma in situ 0 trials · 2,867 incl. sub-types
- Digestive system mixed adenoneuroendocrine carcinoma 0 trials · 2,861 incl. sub-types
- Uterus carcinoma in situ 0 trials · 2,859 incl. sub-types
- Diencephalic cancer 0 trials · 2,858 incl. sub-types
- Ovarian neuroendocrine neoplasm 0 trials · 2,858 incl. sub-types
- Cardia cancer 0 trials · 2,857 incl. sub-types
- Thyroid gland adenocarcinoma 0 trials · 2,857 incl. sub-types
- Pineal gland cancer 0 trials · 2,854 incl. sub-types
- Digestive system melanoma 0 trials · 2,851 incl. sub-types